Belviq side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Belviq. Common side effects include drug ineffective among females, and drug ineffective among males.
The phase IV clinical study is created by eHealthMe based on 3,156 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,156 people who take Belviq and have side effects are studied.
What is Belviq?
Belviq has active ingredients of lorcaserin hydrochloride. It is used in weight loss. Currently, eHealthMe is studying from 3,176 Belviq users.
Number of Belviq reports submitted per year:
Belviq side effects by time on the drug *:
Belviq side effects by gender *:
Belviq side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Belviq?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on lorcaserin hydrochloride (the active ingredients of Belviq) and Belviq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Belviq:
- Belviq (3,176 reports)
Common Belviq side effects:
- Drug ineffective: 536 reports
- Headache (pain in head): 517 reports
- Fatigue (feeling of tiredness): 484 reports
- Dizziness: 381 reports
- Weight increased: 205 reports
- Drowsiness: 146 reports
All Belviq side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zetia and Pindolol drug interaction - 26 seconds ago
- Miglitol and Bethanechol Chloride drug interaction - 39 seconds ago
- Omeprazole and Divalproex Sodium drug interaction - 42 seconds ago
- Belviq and Rashes - 51 seconds ago
- Mobic and Xeloda drug interaction - a minute ago
- Xiidra and Instillation Site Irritation - a minute ago
- Motrin and Mental Status Changes - a minute ago
- Tolterodine and Pain - a minute ago
- Hydrocodone and Acne - a minute ago
- Ibu and Yaz drug interaction - a minute ago